Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver

British Journal of Cancer volume 80, pages 1069–1074 (1999)Cite this article

This article has been updated

Summary

p73, the first homologue of the tumour suppressor protein p53, was recently discovered on chromosome 1p36 and has been shown to induce apoptosis in a p53-like manner. The present study was performed with the aim of investigating the expression of p53, its new homologue p73 and the occurrence of apoptosis in cholangiocellular carcinoma. Protein levels of p73 were examined in 41 patients with curatively (R0-) resected cholangiocellular carcinomas with an antiserum, raised against a peptide in the N-terminal domain of p73. The incidence of mutations in the p53 gene was analysed by direct sequencing and also immunohistochemically. Apoptotic cell death was assessed using in-situ end-labelling (ISEL) technique in combination with morphological criteria. The results obtained were correlated with patient survival. Immunostaining of p73 protein was detected in 17/41 carcinomas examined (41%). The immunoreactivity was confined to the cell nucleus. In 15/41 patients (37%), mutations of the p53 gene were observed. Eleven out of these 15 patients stained also positive for p73. In contrast, out of 26 patients without any detectable p53 mutation, only six exhibited p73 immunostaining. We failed to observe a correlation between p73 expression or p53 and apoptosis within a given tumour. Survival analysis including the parameters stage and grade of disease, p73 and p53, and also apoptosis, showed that tumour stage and grade as well as p53 and p73 were significantly related to prognosis. In Cox regression survival analysis, however, only extent of primary tumour and lymph node status had an independent prognostic impact. Our results with a high prevalence of p73 within tumours harbouring mutated p53 gene suggest that p73 could compensate for p53 function. We failed to establish p73 or p53 as independent prognostic factors in cholangiocellular carcinoma of the liver.

Download PDF

Change history

  • 16 November 2011

    This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication

References

  • Clurman, B. & Groudine, M. (1997). Killer in search of a motive? Nature 389: 122–123.

    CAS  Article  Google Scholar 

  • Harris, C. C. (1996). Molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumour-suppressor gene. Br J Cancer 73: 261–269.

    CAS  Article  Google Scholar 

  • Hui, A-M, Kanai, Y., Sakamoto, M., Tsuda, H. & Hirohashi, S. (1997). Reduced p21WAF1/CIP1 expression and p53 mutation in hepatocellular carcinoma. Hepatology 25: 575–579.

    CAS  Article  Google Scholar 

  • Jost, C. A., Marin, M. C. & Kaelin, W. G. (1997). p73 is a human p53-related protein that can induce apoptosis. Nature 389: 191–194.

    CAS  Article  Google Scholar 

  • Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J. C., Valent, A., Minty, A., Chalon, P., Lelias, J. M., Dumont, X., Ferrara, P., McKeon, F. & Caput, D. (1997). Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90: 809–819.

    CAS  Article  Google Scholar 

  • Mai, M., Yokomizo, A., Quian, C., Yang, P., Tindall, D. J., Smith, D. I. & Liu, W. (1998). Activation of p73 silent allele in lung cancer. Cancer Res 58: 2347–2349.

    CAS  PubMed  Google Scholar 

  • Nomoto, S., Haruki, N., Kondo, N., Konishi, H., Takahashi, T., Takahashi, T. & Takahashi, T. (1998). Search for mutations and examination of allelic expression of the p73 gene at 1p36.33 in human lung cancers. Cancer Res 58: 1380–1383.

    CAS  PubMed  Google Scholar 

  • Ohashi, K., Nakajima, Y., Kanehiro, H., Tsutsumi, M., Taki, J., Aomatsu, Y., Yoshimura, A., Ko, S., Kin, T., Yagura, K., Konishi, Y. & Nakano, H. (1995). Ki-ras mutations and p53 protein expression in intrahepatic cholangiocarcinomas: relation to gross tumor morphology. Gastroenterology 109: 1612–1617.

    CAS  Article  Google Scholar 

  • Orita, M., Suzuki, Y. & Hayashi, K. (1989). Rapid and sensitive detection of point mutation and DNA polymorphisms using the polymerase chain reaction. Genomics 5: 874–879.

    CAS  Article  Google Scholar 

  • Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, pp E3–E4. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory

  • Sun, X. F., Carstensen, J. M., Zhang, H., Stal, O., Wingren, S., Hatschek, T. & Nordenskjöld, B. (1992). Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 340: 1369–1373.

    CAS  Article  Google Scholar 

  • Takahashi, H., Ichimiya, S., Nimura, Y., Watanabe, M., Furusato, M., Wakui, S., Yatani, R., Aizawa, S. & Nakagawara, A. (1998). Mutation, allelotyping, and transcription analysis of the p73 gene in prostatic carcinoma. Cancer Res 58: 2076–2077.

    CAS  PubMed  Google Scholar 

  • Tannapfel, A., Hahn, H., Katalinic, A., Fietkau, R., Kühn, R. & Wittekind, C. H. (1996). Prognostic value of ploidy and proliferation markers in renal cell carcinoma. Cancer 77: 164–171.

    CAS  Article  Google Scholar 

  • Tannapfel, A., Nüsslein, S., Fietkau, R., Katalinic, A., Köckerling, F. & Wittekind, C. (1998). Apoptosis, proliferation, bax, bcl-2 and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer. Int J Radiation Oncol Biol Phys 41: 585–591.

    CAS  Article  Google Scholar 

  • Uhlman, D. L., Nguyen, P. L., Manivel, C., Aeppli, D., Resnick, J. M., Fraley, E. E., Zhang, G. & Niehans, G. A. (1994). Association of immunostaining for p53 with metastatic progression and poor survival in patients with renal cell carcinoma. J Natl Cancer Inst 86: 1470–1475.

    CAS  Article  Google Scholar 

  • Sobin, L. H. & Wittekind, C. H. (eds) (1997). UICC: TNM Classification of Malignant Tumors, 5th edn. New York: Wiley-Liss

    Google Scholar 

  • Ishak, T. et al (1994). WHO: Histological Typing of Tumours of the Liver, 2nd edn. Berlin: Springer Verlag

    Book  Google Scholar 

  • Wittekind, C. (1995). Hepatocellular carcinoma. In Prognostic Factors in Cancer. Hermanek P, Gospodarowicz MK, Henson DE, Hutter RVP and Sobin LH (eds) Berlin: Springer Verlag

    Google Scholar 

Download references

Author information

Affiliations

  1. Institute of Pathology, University of Leipzig, Liebigstr. 26, Leipzig, 04103, Germany

    A Tannapfel, L Weinans & Ch Wittekind

  2. Department of Internal Medicine II, University of Leipzig

    K Engeland & J Mössner

  3. Ph.-Rosenthal-Str. 27, Leipzig, 04103, Germany

    K Engeland & J Mössner

  4. Institute of Cancer Epidemiology, University of Lübeck, St Jürgen-Ring.66, Lübeck, 23564, Germany

    A Katalinic

  5. Department of Surgery II, University of Leipzig

    J Hauss

  6. Liebigstr. 20a, Leipzig, 04103, Germany

    J Hauss

Authors
  1. A Tannapfel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K Engeland
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L Weinans
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Katalinic
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J Hauss
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J Mössner
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ch Wittekind
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/

Reprints and Permissions

About this article

Cite this article

Tannapfel, A., Engeland, K., Weinans, L. et al. Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver. Br J Cancer 80, 1069–1074 (1999). https://doi.org/10.1038/sj.bjc.6690465

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bjc.6690465

Keywords

  • cholangiocellular carcinoma
  • p73
  • p53
  • apoptosis
  • prognosis

Further reading

Search

Advanced search

Quick links